載入...
The revival of CpG oligonucleotide-based cancer immunotherapies
The promising results of clinical trials using immune checkpoint inhibitors revived interests in cancer immunotherapy. However, it also became apparent that efficacy of immune checkpoint blockade can benefit from combining it with immunostimulatory strategies. Here, we review prior and re-emerging a...
Na minha lista:
| 發表在: | Contemp Oncol (Pozn) |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Termedia Publishing House
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5885070/ https://ncbi.nlm.nih.gov/pubmed/29628795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2018.73887 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|